Narayana Hrudayalaya Ltd. has informed the Exchange about Investor Presentation
NH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Narayana Hrudayalaya reported strong Q4 FY26 results with consolidated operating revenues of ₹25,938 Mn (up 75.8% YoY) and full-year FY26 revenues of ₹78,960 Mn (up 44.0% YoY). EBITDA margins improved to 21.7% in FY26 from 20.7% in FY25, while PAT stood at ₹8,105 Mn at a 10.3% margin. The company operates 55 healthcare facilities with 5,945 beds across India, Cayman Islands, and the UK (acquired in November 2025). Net debt to equity ratio is 0.49. Key growth drivers include robotic cardiac surgeries (750+ in FY26), TAVI procedures (160, up 20% YoY), and expansion projects including new hospitals in Bangalore, Kolkata, and Raipur.
Strong revenue growth with margin improvement signals operational efficiency gains. The UK acquisition contribution and new hospital capex pipeline indicate scalable growth. The healthy net debt position reduces financial risk for shareholders.